Policy & Regulation: Page 27
-
PharmaVoice Team/PharmaVoice
Section 199 Deduction for Qualified Production Activity Income
In October of 2004, the U.S. Congress and President Bush signed into law the American Jobs Creation Act of 2004. The Act is the first major corporate tax act in over a decade. A key provision of the Act is a new domestic manufacturing deduction designed to improve the global competitiveness of U....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies New Healthcare Marketing and Communications Agency Created The agency helps clients identify situations and places where behavior can be influenced. Identifying a need to provide clients with a way to compete more effectively in today’s dyn...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineRare diseases
As drug developers find promise in the rare diseases, deals and treatments are on the rise
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies CIS Launches Pharma Compliance Exchange Website Compliance Implementation Services (CIS) recently released the Pharma Compliance Exchange (PCX), a new subscription-based source for government guidance documentation. For the first ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Warwick S. Bedwell Roche Appoints VP and Global Head of Business Development, Pharma Partnering Warwick S. Bedwell has been appointed VP and global head of Roche Pharmaceutical’s Business Development — Pharma Partnering business. Roche, Nutley, N.J., is part of the Roche Group, a rese...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
May 2007 Table of Contents On the Cover Pharma’s Commitment to Public Health A natural extension of the industry’s mission of providing safe, lifesaving medicines is participation and sponsorship of myriad public-health initiatives around the world. Features Nanotech Comes of Age With products al...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
If you are feeling downtrodden by the continuing barrage of negative news about our industry, then this issue is the cure for what ails you. This issue showcases dozens of individuals who exemplify the best of the best in terms of their commitment, passion, and conviction to improving the health ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumer-Driven Healthcare Retail Primary Care One in 10 retail clinic users is replacing his or her primary-care physician with a retail clinic for the treatment of common ailments, according to a recent study by Market Strategies Inc. The study indicates substantial interest by consumers to rec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Connecting the Dots: The Big Picture in Connected Health While the adoption of electronic medical records (EMR) is enormously important — and a robust connected health vision depends on EMR — it is only one aspect of connected health as it exists today and as we envision it for tomorrow. — Joseph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Biotech: The States of the Industry — To harness talent and leverage the niche characteristics to grow business, the biosciences require the specific capabilities certain regions have to offer. In this special Forum, Governors from five biotech-centered states rep...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Hospitals
By Denise Myshko An Opportunity and a Challenge Placement on hospital formularies has become more competitive. Pharmaceutical companies that can demonstrate that their products positively impact the total cost of patient care will have the advantage. While small, the hospital market offers a uniq...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Drug Sales U.S. Prescription Update Sales Jumped 8.3% to $274.9 Billion IMS Health reports that U.S. prescription drug sales grew 8.3% to $274.9 billion in 2006, the third straight year of growth. The increase was fueled by the Medicare Part D prescription benefit, the increased use of generics w...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
etrials Unveils New Version of EDC Solution etrials Worldwide has unveiled EDC 2.0 solution. Combining more than 10 years of market validation and customer deployments, the newest solution builds upon existing Web-based software as a service (SaaS) solution for collecting, managing, and analyzing...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Making Personalized Medicine Understandable Education is Key As William D. Young, CEO of Monogram Bioscience, states in The Age of Personalized Medicine, (PharmaVOICE February 2007), honestly and clearly addressing the concerns of the stakeholders (drug makers, insurance companies, doctors, and p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DNA-Based Diagnostics: Testing for Personalized Medicine
By Cynthia Borda Theranostic testing There will come a time when genetic testing will be as common in the physician’s office as a blood pressure reading or the use of an MRI. The pharmaceutical industry is making headway in the personalized medicine arena, and diagnostic companies are actively de...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Connected Health: The Push for Electronic Medical Records
Connected Health: The Push for Electronic Medical Records By Kim Ribbink While the medical profession has lagged on the use of technology to manage and communicate patient information, increased focus on the use of electronic medical records — from the federal government, doctors’ groups, and pat...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Roche Introduces New Operating Model for its Global R&D Activities The focus is on disease biology areas to enhance alignment of R&D. Roche has introduced a new operating model for its global R&D activities, organized around disease biology areas (DBA). Each DBA covers a range of acti...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Nancy Smerkanich The U.S. Food and Drug Administration (FDA) called a Part 15 (21 CFR Part 15) hearing on Dec. 18, 2006, primarily as “a listening exercise” to gather information so that the agency could move forward to “an all electronic submission environment and electronic data ...
By Nancy Smerkanich • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents April 2007 On the Cover The Evolving Role of the Clinical Project Manager Clinical studies have become more complicated, are multinational, and must adhere to a variety of laws and regulations. As a result, the project manager role has become a core capability needed for drug de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Going Public: Pharma's Commitment to Public Health
By Elisabeth Pena Villarroel Forum The pharmaceutical industry’s commitment to public health is at the core of its very existence; the mission and work of the industry’s companies are to create, develop, and bring to market lifesaving and life-enhancing medicines. A natural extension of this miss...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Evolving Role of the Clinical Project Manager
The Evolving Role of the Clinical Project Manager By Denise Myshko Forum Clinical studies have become more complicated. More studies are multinational, which means that projects must adhere to a variety of regulations and laws. Today’s studies also require project managers to work across teams to...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Eric G. Carter King Appoints Chief Science Officer King Pharmaceuticals, Bristol, Tenn., an integrated branded pharmaceutical company, has appointed Eric G. Carter, M.D., Ph.D., as chief science officer. Dr. Carter oversees King’s R&D, regulatory, and medical-affairs activitie...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Meet the Creative Directors
By Taren Grom, Editor Special Feature PharmaVOICE is pleased to publish this special feature showcasing the individuals who influence the look and feel of the industry through their creative executions and insights, strategic thinking, and mentorship of up-and-coming talent. GETTING PERSONAL ABOU...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Thomson Scientific Expands Pharmaceutical Regulatory Intelligence Coverage Thomson Scientific announces that three new country modules, India, Israel, and Turkey, are now available in IDRAC, the global pharmaceutical regulatory intelligence database. IDRAC is recognized by regulatory professional...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by James Rogers Merging Clinical-Trials Safety and Pharmacovigilance The Winds of change in safety monitoring In November 2003, Mark B. McClellan, M.D., Ph.D., a former commissioner with the Food and Drug Administration, made the comment: “…there is no such thing as a completely safe ...
By James Rogers • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Changes in Washington: Will it Affect the Pharmaceutical Industry? One way that the U.S. government is making good on its promise to reduce the cost of healthcare is by approving Medicare Part D. — Patricia Santos-Serrao, RAC, Regulatory Advisory, Qumas A shift in command Healthcare has always be...
By PharmaVoice Team • Jan. 2, 2008
Previous
